CRSP
USDCRISPR Therapeutics AG Common Shares
$55.120+1.840 (3.453%)
Real-time Price
Healthcare
Biotechnology
Switzerland
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$53.280
High
$55.220
Low
$52.420
Volume
1.90M
Company Fundamentals
Market Cap
5.0B
Industry
Biotechnology
Country
Switzerland
Trading Stats
Avg Volume
2.50M
Exchange
NGM
Currency
USD
52-Week Range
Low $30.04Current $55.120High $78.48
Related News
Analyst Upgrades
Needham Maintains Buy on CRISPR Therapeutics, Lowers Price Target to $80
Needham analyst Gil Blum maintains CRISPR Therapeutics with a Buy and lowers the price target from $81 to $80.
View more
GlobeNewswire
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
-Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions and simultaneously published in The New England Journal of Medicine-
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.